Rezolute, Inc. (RZLT)
4.685
+0.06
(+1.41%)
USD |
NASDAQ |
Aug 31, 16:00
4.685
0.00 (0.00%)
After-Hours: 20:00
Rezolute Cash from Operations (Annual) : -69.08M for June 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| June 30, 2025 | -69.08M |
| June 30, 2024 | -57.37M |
| June 30, 2023 | -44.48M |
| June 30, 2022 | -39.62M |
| June 30, 2021 | -20.44M |
| June 30, 2020 | -24.17M |
| June 30, 2019 | -15.30M |
| June 30, 2018 | -14.11M |
| Date | Value |
|---|---|
| June 30, 2017 | -13.31M |
| June 30, 2016 | -10.49M |
| June 30, 2015 | -7.079M |
| June 30, 2014 | -3.167M |
| June 30, 2013 | -1.628M |
| June 30, 2012 | -0.0404M |
| June 30, 2011 | -0.0048M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.39M |
| AbbVie, Inc. | 19.03B |
| Marker Therapeutics, Inc. | -12.01M |
| Avalo Therapeutics, Inc. | -51.46M |
| Krystal Biotech, Inc. | 200.86M |